News
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Anne Wojcicki lands 23andMe again. What $305 million deal means for company, customers, shareholders
Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...
CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.
Healthcare entrepreneur Ron Zwanziger recently made an unsolicited offer to buy OraSure Technologies, a company known for its COVID-19 rapid tests, according to a report by Reuters. In June, Zwanziger ...
One group of people may receive up to $1,500, and much sooner than they think. There is a catch: only some may qualify for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results